Adrecizumab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Adrecizumab, covering 2017-03-15 to 2021-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Adrecizumab in Cardiogenic Shock [Phase 2, Phase 3]